Concepedia

Publication | Open Access

190TiP: ELUXA 1: Phase II study of BI 1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung cancer (NSCLC) after treatment with an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI)

DOIFull Paper Access

15

Citations

0

References

2016

Year

K. Park, J. Y. Han, D.-W. Kim, Lyudmila Bazhenova, S.-H.I. Ou, Yong Kek Pang, How Soon Hin, Óscar Juan, J. Son, Pasi A. Jänne
Journal of Thoracic Oncology

No additional data available for this publication yet. Check back later!